Peroxisomal proliferator-activated receptor (PPAR) α, a member of the nuclear receptor family, is considered to be a major operator of lipid metabolic homeostasis in the liver, and inhibition of its expression is directly related to the pathogenesis of NAFLD and NASH. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.